These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 23080224)

  • 21. Antiplatelet agents in stroke prevention: acute and long-term treatment strategies.
    Weber R; Weimar C; Diener HC
    Hamostaseologie; 2009 Nov; 29(4):326-33. PubMed ID: 19882077
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aspirin resistance in secondary stroke prevention.
    Berrouschot J; Schwetlick B; von Twickel G; Fischer C; Uhlemann H; Siegemund T; Siegemund A; Roessler A
    Acta Neurol Scand; 2006 Jan; 113(1):31-5. PubMed ID: 16367896
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiplatelet therapy in the prevention of ischaemic stroke.
    Verry M; Panak E; Cazenave JP
    Nouv Rev Fr Hematol (1978); 1994 Jun; 36(3):213-28. PubMed ID: 7971242
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low-dose aspirin for preventing recurrent venous thromboembolism.
    Brighton TA; Eikelboom JW; Mann K; Mister R; Gallus A; Ockelford P; Gibbs H; Hague W; Xavier D; Diaz R; Kirby A; Simes J;
    N Engl J Med; 2012 Nov; 367(21):1979-87. PubMed ID: 23121403
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiplatelet drugs for ischemic stroke prevention.
    Leys D; Balucani C; Cordonnier C
    Cerebrovasc Dis; 2009; 27 Suppl 1():120-5. PubMed ID: 19342841
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial.
    Bhatt DL; Flather MD; Hacke W; Berger PB; Black HR; Boden WE; Cacoub P; Cohen EA; Creager MA; Easton JD; Hamm CW; Hankey GJ; Johnston SC; Mak KH; Mas JL; Montalescot G; Pearson TA; Steg PG; Steinhubl SR; Weber MA; Fabry-Ribaudo L; Hu T; Topol EJ; Fox KA;
    J Am Coll Cardiol; 2007 May; 49(19):1982-8. PubMed ID: 17498584
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aspirin nonresponse in patients with arterial causes of ischemic stroke: considerations in detection and management.
    Biller J
    J Neurol Sci; 2008 Sep; 272(1-2):1-7. PubMed ID: 18534625
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiplatelet therapy use after discharge among acute myocardial infarction patients with in-hospital bleeding.
    Wang TY; Xiao L; Alexander KP; Rao SV; Kosiborod MN; Rumsfeld JS; Spertus JA; Peterson ED
    Circulation; 2008 Nov; 118(21):2139-45. PubMed ID: 18981304
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of cilostazol for secondary stroke prevention: an old dog with new tricks?
    Ansara AJ; Shiltz DL; Slavens JB
    Ann Pharmacother; 2012 Mar; 46(3):394-402. PubMed ID: 22353234
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral anticoagulant and antiplatelet therapy and peripheral arterial disease.
    ; Anand S; Yusuf S; Xie C; Pogue J; Eikelboom J; Budaj A; Sussex B; Liu L; Guzman R; Cina C; Crowell R; Keltai M; Gosselin G
    N Engl J Med; 2007 Jul; 357(3):217-27. PubMed ID: 17634457
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apixaban, an oral, direct, selective factor Xa inhibitor, in combination with antiplatelet therapy after acute coronary syndrome: results of the Apixaban for Prevention of Acute Ischemic and Safety Events (APPRAISE) trial.
    ; Alexander JH; Becker RC; Bhatt DL; Cools F; Crea F; Dellborg M; Fox KA; Goodman SG; Harrington RA; Huber K; Husted S; Lewis BS; Lopez-Sendon J; Mohan P; Montalescot G; Ruda M; Ruzyllo W; Verheugt F; Wallentin L
    Circulation; 2009 Jun; 119(22):2877-85. PubMed ID: 19470889
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect and safety of the antithrombotic therapies in patients with atrial fibrillation and CHADS score 1.
    Lee BH; Park JS; Park JH; Park JS; Kwak JJ; Hwang ES; Kim SK; Choi DH; Kim YH; Pak HN
    J Cardiovasc Electrophysiol; 2010 May; 21(5):501-7. PubMed ID: 20021521
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical features in liver cirrhosis patients who have experienced ischemic stroke.
    Kim KM; Hwang JW; Shim SG
    Turk J Gastroenterol; 2014 Dec; 25(6):696-701. PubMed ID: 25599784
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Platelet aggregation test: application in the control of antiplatelet aggregation in the secondary prevention of stroke].
    Piedade PR; Gagliardi RJ; Damiani IT; Nassar Junior AP; Fuzaro MM; Sanvito WL
    Arq Neuropsiquiatr; 2003 Sep; 61(3B):764-7. PubMed ID: 14595479
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A curious case of unilateral spider nevi, cirrhosis and stroke: unilateral nevoid telangiectasia syndrome.
    Park JJ; Yeo JM; Hayes P
    J R Coll Physicians Edinb; 2013; 43(3):222-4. PubMed ID: 24087800
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ischaemic stroke in patients with liver cirrhosis.
    Ponzetto A; Diella FA; Figura N
    Eur J Gastroenterol Hepatol; 2018 Jun; 30(6):689. PubMed ID: 29697527
    [No Abstract]   [Full Text] [Related]  

  • 37. Cirrhosis of the liver and liver therapy.
    SACHS A
    J Omaha Midwest Clin Soc; 1947 Apr; 8(2):56-62. PubMed ID: 20294793
    [No Abstract]   [Full Text] [Related]  

  • 38. [Conservative therapy of liver cirrhosis].
    KIERST W
    Pol Arch Med Wewn; 1962; 32():1447-53. PubMed ID: 14032533
    [No Abstract]   [Full Text] [Related]  

  • 39. [Surgical therapy of liver cirrhosis].
    CZYZEWSKI K
    Pol Arch Med Wewn; 1962; 32():1455-60. PubMed ID: 14024491
    [No Abstract]   [Full Text] [Related]  

  • 40. [The efficacy and safety of antiplatelet monotherapy in patients with ischemic stroke in the real world].
    Liu LP
    Zhonghua Nei Ke Za Zhi; 2019 Apr; 58(4):324-328. PubMed ID: 30917431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.